Chemo-Pharma Laboratories Live BSE/NSE | Chemo-Pharma Laboratories Fundamenta data | Chemo-Pharma Laboratories Balance sheet | Chemo-Pharma Laboratories Quarterly Results | Chemo-Pharma Laboratories Profit & Loss | Chemo-Pharma Laboratories Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4.60
16.84
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

-4.21
N/A
0.42

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

9.25
8.66
8.14

P:BV (Average)

8 Years
5 Years
3 Years

0.23
0.23
0.23

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.82
-2.32
-8.71

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.04 0.10 -60.00% 0.07 0.13 -46.15% 0.16 0.14 14.29% 0.08 0.13 -38.46%
EBITDA -0.04 -0.10 - -0.07 -0.13 - -0.16 -0.14 - -0.08 -0.13 -
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.14 0.28 -50.00% 0.16 0.28 -42.86% 0.29 0.43 -32.56% 0.15 0.14 7.14%
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00
PBT 0.10 0.18 -44.44% 0.09 0.15 -40.00% 0.10 0.29 -65.52% 0.07 0.01 600.00%
Tax 0.00 0.00 0.00 0.01 0.00 0.00 0.08 0.05 60.00% 0.00 0.00 0.00
PAT 0.10 0.18 -44.44% 0.08 0.15 -46.67% 0.02 0.24 -91.67% 0.07 0.01 600.00%
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.67 1.19 -43.70% 0.56 1.01 -44.55% 0.13 1.62 -91.98% 0.46 0.08 475.00%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Net Sales Growth 0.00% 0 0 0 0 0 0 0 0 0 Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 GP Margin 0.00% 0 0 0 0 0 0 0 0 0 0 Total Expenditure 0.35 0.48 0.56 0.34 0.27 0.17 0.12 0.13 0.08 0.12 0.02 Power & Fuel Cost - 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0 0 0 0 0 0 0 0 0 0 Employee Cost - 0.16 0.21 0.13 0.06 0.03 0.01 0.00 0.00 0.02 0.00 % Of Sales - 0 0 0 0 0 0 0 0 0 0 Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0 0 0 0 0 0 0 0 0 0 General & Admin Exp. - 0.25 0.32 0.21 0.16 0.13 0.11 0.13 0.08 0.10 0.02 % Of Sales - 0 0 0 0 0 0 0 0 0 0 Selling & Distn. Exp. - 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0 0 0 0 0 0 0 0 0 0 Miscellaneous Exp. - 0.04 0.00 0.00 0.06 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0 0 0 0 0 0 0 0 0 0 EBITDA -0.35 -0.48 -0.56 -0.34 -0.27 -0.17 -0.12 -0.13 -0.08 -0.12 -0.02 EBITDA Margin 0.00% 0 0 0 0 0 0 0 0 0 0 Other Income 0.74 1.00 0.82 1.11 5.61 0.49 0.50 0.44 0.27 1.07 0.04 Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Depreciation 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 PBT 0.36 0.49 0.25 0.76 5.34 0.32 0.38 0.30 0.18 0.93 0.00 Tax 0.09 0.08 0.05 0.66 0.65 0.10 0.10 0.06 0.04 0.09 0.00 Tax Rate 25.00% 16.33% 20.00% 86.84% 12.17% 31.25% 26.32% 20.00% 22.22% 9.68% 0.00% PAT 0.27 0.42 0.21 0.10 4.68 0.22 0.28 0.24 0.14 0.85 0.00 PAT before Minority Interest 0.27 0.42 0.21 0.10 4.68 0.22 0.28 0.24 0.14 0.85 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.00% 0 0 0 0 0 0 0 0 0 0 PAT Growth -53.45% 100% 110.0% -97.86% 2027.27% -21.43% 16.67% 71.43% -83.53% 0 Unadjusted EPS 1.80 2.80 1.40 0.67 31.20 1.47 1.87 1.60 0.93 5.67 0.00

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

0.00

Net Sales Growth

0.00%

Cost Of Goods Sold

0.00

Gross Profit

0.00

GP Margin

0.00%

Total Expenditure

0.35

0.48

0.56

0.34

0.27

0.17

0.12

0.13

0.08

0.12

0.02

Power & Fuel Cost

0.02

0.00

% Of Sales

Employee Cost

0.16

0.21

0.13

0.06

0.03

0.01

0.00

0.02

0.00

% Of Sales

Manufacturing Exp.

0.00

% Of Sales

General & Admin Exp.

0.25

0.32

0.21

0.16

0.13

0.11

0.13

0.08

0.10

0.02

% Of Sales

Selling & Distn. Exp.

0.01

0.00

% Of Sales

Miscellaneous Exp.

0.04

0.00

0.06

0.00

% Of Sales

EBITDA

-0.35

-0.48

-0.56

-0.34

-0.27

-0.17

-0.12

-0.13

-0.08

-0.12

-0.02

EBITDA Margin

0.00%

Other Income

0.74

1.00

0.82

1.11

5.61

0.49

0.50

0.44

0.27

1.07

0.04

Interest

0.00

Depreciation

0.02

0.00

0.01

PBT

0.36

0.49

0.25

0.76

5.34

0.32

0.38

0.30

0.18

0.93

0.00

Tax

0.09

0.08

0.05

0.66

0.65

0.10

0.06

0.04

0.09

0.00

Tax Rate

25.00%

16.33%

20.00%

86.84%

12.17%

31.25%

26.32%

20.00%

22.22%

9.68%

0.00%

PAT

0.27

0.42

0.21

0.10

4.68

0.22

0.28

0.24

0.14

0.85

0.00

PAT before Minority Interest

0.27

0.42

0.21

0.10

4.68

0.22

0.28

0.24

0.14

0.85

0.00

Minority Interest

0.00

PAT Margin

0.00%

PAT Growth

-53.45%

100%

110.0%

-97.86%

2027.27%

-21.43%

16.67%

71.43%

-83.53%

Unadjusted EPS

1.80

2.80

1.40

0.67

31.20

1.47

1.87

1.60

0.93

5.67

0.00

Description TTM Mar 16
Net Sales - 0.00 Net Sales Growth - Cost Of Goods Sold - 0.00 Gross Profit - 0.00 GP Margin - 0 Total Expenditure - 1.84 Power & Fuel Cost - 0.00 % Of Sales - 0 Employee Cost - 0.03 % Of Sales - 0 Manufacturing Exp. - 0.00 % Of Sales - 0 General & Admin Exp. - 0.13 % Of Sales - 0 Selling & Distn. Exp. - 0.00 % Of Sales - 0 Miscellaneous Exp. - 1.67 % Of Sales - 0 EBITDA - -1.84 EBITDA Margin - 0 Other Income - 0.49 Interest - 0.00 Depreciation - 0.00 PBT - -1.35 Tax - 0.10 Tax Rate - -7.41% PAT - -1.45 PAT before Minority Interest - -1.45 Minority Interest - 0.00 PAT Margin - 0 PAT Growth - Unadjusted EPS - -9.67

Description

TTM

Mar 16

Net Sales

0.00

Net Sales Growth

Cost Of Goods Sold

0.00

Gross Profit

0.00

GP Margin

Total Expenditure

1.84

Power & Fuel Cost

0.00

% Of Sales

Employee Cost

0.03

% Of Sales

Manufacturing Exp.

0.00

% Of Sales

General & Admin Exp.

0.13

% Of Sales

Selling & Distn. Exp.

0.00

% Of Sales

Miscellaneous Exp.

1.67

% Of Sales

EBITDA

-1.84

EBITDA Margin

Other Income

0.49

Interest

0.00

Depreciation

0.00

PBT

-1.35

Tax

0.10

Tax Rate

-7.41%

PAT

-1.45

PAT before Minority Interest

-1.45

Minority Interest

0.00

PAT Margin

PAT Growth

Unadjusted EPS

-9.67

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 10.74 10.33 10.12 10.02 5.34 5.12 4.85 4.61 4.47 3.62 Share Capital 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 Total Reserves 9.24 8.83 8.62 8.52 3.84 3.62 3.35 3.11 2.97 2.12 Non-Current Liabilities 0.00 0.00 0.00 0.12 0.12 0.12 0.12 0.12 0.12 0.12 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.12 0.12 0.12 0.12 0.12 0.12 0.12 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 0.22 0.09 0.13 0.58 0.08 0.34 0.23 0.15 0.22 0.60 Trade Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.05 Other Current Liabilities 0.14 0.13 0.12 0.03 0.05 0.05 0.05 0.03 0.10 0.12 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.43 Short Term Provisions 0.08 -0.03 0.01 0.55 0.02 0.28 0.18 0.12 0.08 0.00 Total Liabilities 10.96 10.42 10.25 10.72 5.54 5.58 5.20 4.88 4.81 4.34 Net Block 0.07 0.00 0.00 0.01 0.00 0.00 0.01 0.02 0.02 0.03 Gross Block 0.11 0.01 0.01 0.09 0.09 0.09 0.09 0.09 0.09 0.09 Accumulated Depreciation 0.03 0.01 0.00 0.08 0.08 0.08 0.07 0.07 0.06 0.06 Non Current Assets 2.06 1.88 1.71 1.60 3.34 3.45 3.52 3.32 3.28 4.33 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.02 0.04 0.02 0.02 1.68 1.68 1.68 1.68 1.68 2.83 Long Term Loans & Adv. 1.96 1.84 1.69 1.57 1.66 1.76 1.83 1.62 1.57 1.46 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 8.91 8.54 8.55 9.12 2.19 2.13 1.68 1.56 1.53 0.01 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash & Bank 8.81 2.97 7.66 6.87 0.44 0.38 0.17 0.20 0.37 0.01 Other Current Assets 0.10 0.00 0.05 0.00 1.75 1.75 1.50 1.35 1.16 0.00 Short Term Loans & Adv. 0.10 5.57 0.84 2.25 1.75 1.75 1.50 1.35 1.16 0.00 Net Current Assets 8.69 8.45 8.41 8.55 2.11 1.79 1.45 1.41 1.30 -0.59 Total Assets 10.97 10.42 10.26 10.72 5.53 5.58 5.20 4.88 4.81 4.34

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

10.74

10.33

10.12

10.02

5.34

5.12

4.85

4.61

4.47

3.62

Share Capital

1.50

Total Reserves

9.24

8.83

8.62

8.52

3.84

3.62

3.35

3.11

2.97

2.12

Non-Current Liabilities

0.00

0.12

Secured Loans

0.00

Unsecured Loans

0.00

0.12

Long Term Provisions

0.00

Current Liabilities

0.22

0.09

0.13

0.58

0.08

0.34

0.23

0.15

0.22

0.60

Trade Payables

0.00

0.04

0.05

Other Current Liabilities

0.14

0.13

0.12

0.03

0.05

0.03

0.10

0.12

Short Term Borrowings

0.00

0.43

Short Term Provisions

0.08

-0.03

0.01

0.55

0.02

0.28

0.18

0.12

0.08

0.00

Total Liabilities

10.96

10.42

10.25

10.72

5.54

5.58

5.20

4.88

4.81

4.34

Net Block

0.07

0.00

0.01

0.00

0.01

0.02

0.03

Gross Block

0.11

0.01

0.09

Accumulated Depreciation

0.03

0.01

0.00

0.08

0.07

0.06

Non Current Assets

2.06

1.88

1.71

1.60

3.34

3.45

3.52

3.32

3.28

4.33

Capital Work in Progress

0.00

Non Current Investment

0.02

0.04

0.02

1.68

2.83

Long Term Loans & Adv.

1.96

1.84

1.69

1.57

1.66

1.76

1.83

1.62

1.57

1.46

Other Non Current Assets

0.00

Current Assets

8.91

8.54

8.55

9.12

2.19

2.13

1.68

1.56

1.53

0.01

Current Investments

0.00

Inventories

0.00

Sundry Debtors

0.00

Cash & Bank

8.81

2.97

7.66

6.87

0.44

0.38

0.17

0.20

0.37

0.01

Other Current Assets

0.10

0.00

0.05

0.00

1.75

1.50

1.35

1.16

0.00

Short Term Loans & Adv.

0.10

5.57

0.84

2.25

1.75

1.50

1.35

1.16

0.00

Net Current Assets

8.69

8.45

8.41

8.55

2.11

1.79

1.45

1.41

1.30

-0.59

Total Assets

10.97

10.42

10.26

10.72

5.53

5.58

5.20

4.88

4.81

4.34

Description Mar 16
Shareholder's Funds 3.67 Share Capital 1.50 Total Reserves 2.17 Non-Current Liabilities 0.12 Secured Loans 0.00 Unsecured Loans 0.12 Long Term Provisions 0.00 Current Liabilities 0.08 Trade Payables 0.00 Other Current Liabilities 0.05 Short Term Borrowings 0.00 Short Term Provisions 0.02 Total Liabilities 3.87 Net Block 0.00 Gross Block 0.09 Accumulated Depreciation 0.08 Non Current Assets 1.68 Capital Work in Progress 0.00 Non Current Investment 0.02 Long Term Loans & Adv. 1.66 Other Non Current Assets 0.00 Current Assets 2.19 Current Investments 0.00 Inventories 0.00 Sundry Debtors 0.00 Cash & Bank 0.44 Other Current Assets 1.75 Short Term Loans & Adv. 1.75 Net Current Assets 2.11 Total Assets 3.87

Description

Mar 16

Shareholder's Funds

3.67

Share Capital

1.50

Total Reserves

2.17

Non-Current Liabilities

0.12

Secured Loans

0.00

Unsecured Loans

0.12

Long Term Provisions

0.00

Current Liabilities

0.08

Trade Payables

0.00

Other Current Liabilities

0.05

Short Term Borrowings

0.00

Short Term Provisions

0.02

Total Liabilities

3.87

Net Block

0.00

Gross Block

0.09

Accumulated Depreciation

0.08

Non Current Assets

1.68

Capital Work in Progress

0.00

Non Current Investment

0.02

Long Term Loans & Adv.

1.66

Other Non Current Assets

0.00

Current Assets

2.19

Current Investments

0.00

Inventories

0.00

Sundry Debtors

0.00

Cash & Bank

0.44

Other Current Assets

1.75

Short Term Loans & Adv.

1.75

Net Current Assets

2.11

Total Assets

3.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 4.83 -5.48 -1.66 6.41 -0.43 -0.05 -0.17 -0.40 -1.48 0.42 PBT 0.49 0.25 0.76 5.34 0.32 0.38 0.30 0.18 0.93 0.00 Adjustment -0.97 -0.80 -1.08 -0.52 -0.49 -0.50 -0.43 -0.26 -1.13 -0.03 Changes in Working Capital 5.39 -4.89 -0.68 2.25 -0.18 0.14 0.01 -0.26 -1.18 0.45 Cash after chg. in Working capital 4.91 -5.44 -1.00 7.06 -0.35 0.02 -0.12 -0.35 -1.37 0.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.08 -0.05 -0.66 -0.65 -0.08 -0.08 -0.04 -0.05 -0.11 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 1.01 0.79 1.08 0.52 0.49 0.25 0.14 0.23 2.28 -0.85 Net Fixed Assets -0.10 0.00 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Net Investments 0.02 -0.02 0.00 1.66 0.00 0.00 0.00 0.00 1.15 -0.85 Others 1.09 0.81 1.00 -1.14 0.49 0.25 0.14 0.23 1.13 0.00 Cash from Financing Activity 0.00 0.00 1.37 -0.50 0.00 0.00 0.00 0.00 -0.43 0.43 Net Cash Inflow / Outflow 5.84 -4.70 0.79 6.43 0.06 0.20 -0.03 -0.17 0.37 0.00 Opening Cash & Equivalents 2.97 7.66 6.87 0.44 0.38 0.17 0.20 0.37 0.01 0.01 Closing Cash & Equivalent 8.81 2.97 7.66 6.87 0.44 0.38 0.17 0.20 0.37 0.01

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

4.83

-5.48

-1.66

6.41

-0.43

-0.05

-0.17

-0.40

-1.48

0.42

PBT

0.49

0.25

0.76

5.34

0.32

0.38

0.30

0.18

0.93

0.00

Adjustment

-0.97

-0.80

-1.08

-0.52

-0.49

-0.50

-0.43

-0.26

-1.13

-0.03

Changes in Working Capital

5.39

-4.89

-0.68

2.25

-0.18

0.14

0.01

-0.26

-1.18

0.45

Cash after chg. in Working capital

4.91

-5.44

-1.00

7.06

-0.35

0.02

-0.12

-0.35

-1.37

0.42

Interest Paid

0.00

Tax Paid

-0.08

-0.05

-0.66

-0.65

-0.08

-0.04

-0.05

-0.11

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

1.01

0.79

1.08

0.52

0.49

0.25

0.14

0.23

2.28

-0.85

Net Fixed Assets

-0.10

0.00

0.08

0.00

Net Investments

0.02

-0.02

0.00

1.66

0.00

1.15

-0.85

Others

1.09

0.81

1.00

-1.14

0.49

0.25

0.14

0.23

1.13

0.00

Cash from Financing Activity

0.00

1.37

-0.50

0.00

-0.43

0.43

Net Cash Inflow / Outflow

5.84

-4.70

0.79

6.43

0.06

0.20

-0.03

-0.17

0.37

0.00

Opening Cash & Equivalents

2.97

7.66

6.87

0.44

0.38

0.17

0.20

0.37

0.01

Closing Cash & Equivalent

8.81

2.97

7.66

6.87

0.44

0.38

0.17

0.20

0.37

0.01

Description Mar 16
Cash From Operating Activity -2.09 PBT -1.35 Adjustment -0.49 Changes in Working Capital -0.18 Cash after chg. in Working capital -2.01 Interest Paid 0.00 Tax Paid -0.08 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity 2.15 Net Fixed Assets Net Investments Others Cash from Financing Activity 0.00 Net Cash Inflow / Outflow 0.06 Opening Cash & Equivalents 0.38 Closing Cash & Equivalent 0.44

Description

Mar 16

Cash From Operating Activity

-2.09

PBT

-1.35

Adjustment

-0.49

Changes in Working Capital

-0.18

Cash after chg. in Working capital

-2.01

Interest Paid

0.00

Tax Paid

-0.08

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

2.15

Net Fixed Assets

Net Investments

Others

Cash from Financing Activity

0.00

Net Cash Inflow / Outflow

0.06

Opening Cash & Equivalents

0.38

Closing Cash & Equivalent

0.44

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 71.63 68.86 67.49 66.82 35.59 34.14 32.34 30.73 29.77 24.12 ROA 3.88% 2.00% 0.96% 57.64% 3.90% 5.20% 4.79% 2.96% 18.55% 0.08% ROE 3.94% 2.02% 1.00% 60.99% 4.15% 5.61% 5.10% 3.16% 20.98% 0.10% ROCE 4.69% 2.50% 7.54% 68.41% 5.96% 7.52% 6.22% 3.85% 21.34% 0.09% Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Receivable days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 306.06 389.41 1743.59 Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -306.06 -389.41 -1743.59 Total Debt/Equity 0.00 0.00 0.00 0.01 0.02 0.02 0.02 0.03 0.03 0.15 Interest Cover 2028.63 467.57 2624.22 0.00 2685.32 5333.02 2183.93 351.67 4944.34 23.63

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

71.63

68.86

67.49

66.82

35.59

34.14

32.34

30.73

29.77

24.12

ROA

3.88%

2.00%

0.96%

57.64%

3.90%

5.20%

4.79%

2.96%

18.55%

0.08%

ROE

3.94%

2.02%

1.00%

60.99%

4.15%

5.61%

5.10%

3.16%

20.98%

0.10%

ROCE

4.69%

2.50%

7.54%

68.41%

5.96%

7.52%

6.22%

3.85%

21.34%

0.09%

Fixed Asset Turnover

0.00

Receivable days

0.00

Inventory Days

0.00

Payable days

0.00

306.06

389.41

1743.59

Cash Conversion Cycle

0.00

-306.06

-389.41

-1743.59

Total Debt/Equity

0.00

0.01

0.02

0.03

0.15

Interest Cover

2028.63

467.57

2624.22

0.00

2685.32

5333.02

2183.93

351.67

4944.34

23.63

Description Mar 16
Book Value (Rs.) 24.49 ROA -37.45% ROE -39.44% ROCE -35.51% Fixed Asset Turnover 0.00 Receivable days 0.00 Inventory Days 0.00 Payable days 0.00 Cash Conversion Cycle 0.00 Total Debt/Equity 0.03 Interest Cover 0.00

Chemo-Pharma Laboratories Ltd.

Trading

BSE: 506365 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update

Chemo-Pharma Laboratories Ltd.

Trading

BSE: 506365 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update